Iovance Biotherapeutics Correlations

IOVA Stock  USD 10.59  1.69  13.76%   
The correlation of Iovance Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Iovance Biotherapeutics Correlation With Market

Modest diversification

The correlation between Iovance Biotherapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.

Moving together with Iovance Stock

  0.68VANI Vivani Medical Earnings Call TomorrowPairCorr
  0.63VCEL Vericel Corp OrdPairCorr

Moving against Iovance Stock

  0.58DOMH Dominari HoldingsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RAINAPLS
RAINMRTX
MRTXAPLS
APLSKRYS
RAINSRPT
MRTXSRPT
  
High negative correlations   
RAINCWBR
APLSPTCT
MRTXPTCT
CWBRAPLS
CWBRMRTX
CWBRSRPT

Risk-Adjusted Indicators

There is a big difference between Iovance Stock performing well and Iovance Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iovance Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Iovance Biotherapeutics Corporate Management

Esq JDPresident, CEOProfile
Igor BilinskyChief OfficerProfile
Friedrich MDChief OfficerProfile
Howard MBAChief OfficerProfile
Kevin SmythExecutive QualityProfile
JeanMarc MBAChief OfficerProfile
Sara PellegrinoVice RelationsProfile